Lung Kee Group Holdings Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di Lung Kee Group Holdings.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Machinery crescita degli utili	16.0%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Recent updates

Lung Kee (Bermuda) Holdings Limited's (HKG:255) Business Is Trailing The Industry But Its Shares Aren't

Jan 09

Lung Kee (Bermuda) Holdings (HKG:255) Is Paying Out Less In Dividends Than Last Year

Aug 28

Lung Kee (Bermuda) Holdings (HKG:255) Will Pay A Smaller Dividend Than Last Year

May 30

Lung Kee (Bermuda) Holdings' (HKG:255) Dividend Will Be Reduced To HK$0.06

Apr 04

Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15

Aug 29

Something To Consider Before Buying Lung Kee (Bermuda) Holdings Limited (HKG:255) For The 9.1% Dividend

Mar 29

What These Trends Mean At Lung Kee (Bermuda) Holdings (HKG:255)

Mar 09

Estimating The Intrinsic Value Of Lung Kee (Bermuda) Holdings Limited (HKG:255)

Feb 16

Here's What Lung Kee (Bermuda) Holdings Limited's (HKG:255) Shareholder Ownership Structure Looks Like

Jan 29

If You Had Bought Lung Kee (Bermuda) Holdings (HKG:255) Shares Three Years Ago You'd Have A Total Return Of Negative 12%

Jan 10

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Dec 20

Are Dividend Investors Making A Mistake With Lung Kee (Bermuda) Holdings Limited (HKG:255)?

Dec 01

Here's What's Concerning About Lung Kee (Bermuda) Holdings (HKG:255)

Nov 18

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Lung Kee Group Holdings non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SEHK:255 - Stime future degli analisti e dati finanziari passati (HKD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	1,530	-65	116	175	N/A
3/31/2024	1,492	-69	40	126	N/A
12/31/2023	1,454	-72	-36	77	N/A
9/30/2023	1,430	-65	-60	66	N/A
6/30/2023	1,406	-57	-84	55	N/A
3/31/2023	1,506	-20	-95	66	N/A
12/31/2022	1,605	16	-105	77	N/A
9/30/2022	1,800	88	-114	90	N/A
6/30/2022	1,994	161	-122	103	N/A
3/31/2022	2,135	194	15	228	N/A
12/31/2021	2,276	228	152	354	N/A
9/30/2021	2,287	225	223	405	N/A
6/30/2021	2,298	222	294	455	N/A
3/31/2021	2,182	202	268	405	N/A
12/31/2020	2,065	181	242	355	N/A
9/30/2020	2,089	164	237	331	N/A
6/30/2020	2,112	146	231	307	N/A
3/31/2020	2,195	148	241	320	N/A
12/31/2019	2,278	149	250	332	N/A
9/30/2019	2,307	133	279	362	N/A
6/30/2019	2,335	117	308	391	N/A
3/31/2019	2,458	144	272	357	N/A
12/31/2018	2,580	171	237	323	N/A
9/30/2018	2,628	211	190	284	N/A
6/30/2018	2,675	251	144	245	N/A
3/31/2018	2,593	265	N/A	238	N/A
12/31/2017	2,510	278	N/A	231	N/A
9/30/2017	2,432	273	N/A	283	N/A
6/30/2017	2,354	267	N/A	336	N/A
3/31/2017	2,284	230	N/A	410	N/A
12/31/2016	2,213	192	N/A	485	N/A
9/30/2016	2,187	164	N/A	491	N/A
6/30/2016	2,160	136	N/A	498	N/A
3/31/2016	2,220	131	N/A	435	N/A
12/31/2015	2,279	126	N/A	373	N/A
9/30/2015	2,358	132	N/A	309	N/A
6/30/2015	2,436	139	N/A	245	N/A
3/31/2015	2,420	139	N/A	201	N/A
12/31/2014	2,403	138	N/A	158	N/A
9/30/2014	2,352	138	N/A	173	N/A
6/30/2014	2,300	138	N/A	188	N/A
3/31/2014	2,261	142	N/A	219	N/A
12/31/2013	2,221	145	N/A	249	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista 255 è superiore al tasso di risparmio ( 2.3% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di 255 cresceranno più velocemente del mercato Hong Kong

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di 255 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di 255 cresceranno più rapidamente del mercato Hong Kong.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di 255 cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di 255 è previsto essere elevato tra 3 anni

Lung Kee Group Holdings Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2022

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Recent updates

Lung Kee Group Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2024, Payable on 24 September 2024

Lung Kee Group Holdings Limited to Report First Half, 2024 Results on Aug 23, 2024

Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2023

Lung Kee (Bermuda) Holdings Limited, Annual General Meeting, May 27, 2024

Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2023 Results on Mar 22, 2024

Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares

Lung Kee (Bermuda) Holdings Limited Announces Voluntary Delist of Shares

Lung Kee (Bermuda) Holdings Limited's (HKG:255) Business Is Trailing The Industry But Its Shares Aren't

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Upcoming dividend of HK$0.05 per share at 7.6% yield

Lung Kee (Bermuda) Holdings (HKG:255) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: HK$0.05 loss per share (vs HK$0.065 profit in 1H 2022)

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2023 Results on Aug 25, 2023

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Lung Kee (Bermuda) Holdings (HKG:255) Will Pay A Smaller Dividend Than Last Year

Lung Kee (Bermuda) Holdings Limited Approves Final Dividend for the Year Ended 31 December, 2022

Upcoming dividend of HK$0.06 per share at 5.9% yield

Lung Kee (Bermuda) Holdings' (HKG:255) Dividend Will Be Reduced To HK$0.06

Full year 2022 earnings released: EPS: HK$0.025 (vs HK$0.36 in FY 2021)

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2022

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Upcoming dividend of HK$0.06 per share

Lung Kee (Bermuda) Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2022, Payable on September 27, 2022

First half 2022 earnings released: EPS: HK$0.065 (vs HK$0.17 in 1H 2021)

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2022 Results on Aug 26, 2022

Investor sentiment deteriorated over the past week

Lung Kee (Bermuda) Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Lung Kee (Bermuda) Holdings Limited Declares Final Dividend

Upcoming dividend of HK$0.20 per share

Less than half of directors are independent

Lung Kee (Bermuda) Holdings Limited Appoints Ms. He Lamei as Independent Non-Executive Director, Member of Each of the Audit Committee, the Nomination Committee and the Remuneration Committee

Upcoming dividend of HK$0.15 per share

First half 2021 earnings released: EPS HK$0.17 (vs HK$0.11 in 1H 2020)

Lung Kee (Bermuda) Holdings (HKG:255) Is Increasing Its Dividend To HK$0.15

Investor sentiment improved over the past week

Lung Kee (Bermuda) Holdings Limited Approves and Declares Final Special Dividend

Upcoming dividend of HK$0.28 per share

Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019)

Something To Consider Before Buying Lung Kee (Bermuda) Holdings Limited (HKG:255) For The 9.1% Dividend

Lung Kee (Bermuda) Holdings Limited Recommends Final Special Dividend for the Year Ended 31 December, 2020, Payable on or About 22 June, 2021

Full year 2020 earnings released: EPS HK$0.29 (vs HK$0.24 in FY 2019)

Lung Kee (Bermuda) Holdings Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

What These Trends Mean At Lung Kee (Bermuda) Holdings (HKG:255)

Estimating The Intrinsic Value Of Lung Kee (Bermuda) Holdings Limited (HKG:255)

Here's What Lung Kee (Bermuda) Holdings Limited's (HKG:255) Shareholder Ownership Structure Looks Like

If You Had Bought Lung Kee (Bermuda) Holdings (HKG:255) Shares Three Years Ago You'd Have A Total Return Of Negative 12%

New 90-day high: HK$2.61

What We Learned About Lung Kee (Bermuda) Holdings' (HKG:255) CEO Compensation

Are Dividend Investors Making A Mistake With Lung Kee (Bermuda) Holdings Limited (HKG:255)?

Here's What's Concerning About Lung Kee (Bermuda) Holdings (HKG:255)

New 90-day high: HK$2.50

New 90-day high: HK$2.32

New 90-day high - HK$2.26

First half earnings released

Lung Kee (Bermuda) Holdings Limited to Report First Half, 2020 Results on Aug 28, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita